130 related articles for article (PubMed ID: 35811033)
1. Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response.
Yang B; Luo W; Wang M; Tang Y; Zhu W; Jin L; Wang M; Wang Y; Zhang Y; Zuo W; Huang LJ; Zhao Y; Liang G
Biochim Biophys Acta Mol Basis Dis; 2022 Oct; 1868(10):166480. PubMed ID: 35811033
[TBL] [Abstract][Full Text] [Related]
2. Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation.
Wang MX; Luo W; Ye L; Jin LM; Yang B; Zhang QH; Qian JC; Wang Y; Zhang Y; Liang G
Acta Pharmacol Sin; 2023 Jan; 44(1):120-132. PubMed ID: 35689091
[TBL] [Abstract][Full Text] [Related]
3. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
6. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
8. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
9. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
Wang L; Jia Z; Wang B; Zhang B
Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-specific FGFR1 deletion alleviates high-fat-diet-induced liver inflammation by inhibiting the MAPKs/TNF pathways.
Zhao YN; Liu ZD; Yan T; Xu TX; Jin TY; Jiang YS; Zuo W; Lee KY; Huang LJ; Wang Y
Acta Pharmacol Sin; 2024 May; 45(5):988-1001. PubMed ID: 38279043
[TBL] [Abstract][Full Text] [Related]
11. Chlorogenic acid ameliorated non-alcoholic steatohepatitis via alleviating hepatic inflammation initiated by LPS/TLR4/MyD88 signaling pathway.
Gu X; Wei M; Hu F; Ouyang H; Huang Z; Lu B; Ji L
Chem Biol Interact; 2023 May; 376():110461. PubMed ID: 36965689
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
13. Macrophage SCAP Contributes to Metaflammation and Lean NAFLD by Activating STING-NF-κB Signaling Pathway.
Huang X; Yao Y; Hou X; Wei L; Rao Y; Su Y; Zheng G; Ruan XZ; Li D; Chen Y
Cell Mol Gastroenterol Hepatol; 2022; 14(1):1-26. PubMed ID: 35367665
[TBL] [Abstract][Full Text] [Related]
14. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
15. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
16. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; Cordell HJ; Topal B; Clément K; Romeo S; Ratziu V; Roskams T; Daly AK; Anstee QM; Trost M; Härtlova A
J Hepatol; 2022 May; 76(5):1001-1012. PubMed ID: 34942286
[TBL] [Abstract][Full Text] [Related]
17. Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages.
Yi YS; Kim HG; Kim JH; Yang WS; Kim E; Jeong D; Park JG; Aziz N; Kim S; Parameswaran N; Cho JY
Front Immunol; 2021; 12():767366. PubMed ID: 35003083
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
[TBL] [Abstract][Full Text] [Related]
20. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
